Obesity and Diabetes Prevention
Research from MedImmune, Inc. provides new data on obesity and diabetes prevention
Published in Health Business Week, June 19th, 2009
A report, 'Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors,' is newly published data in Neoplasia. "EphA2 is a receptor tyrosine kinase that has been shown to be overexpressed in a variety of human tumor types. Previous studies demonstrated that agonist monoclonal antibodies targeting EphA2 induced the internalization and degradation of the receptor, thereby abolishing its oncogenic effects," scientists in the United States report.
"In this study, the in vitro and in vivo antibody-dependent cell-mediated cytotoxicity (ADCC) activity of EphA2 effector-enhanced...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2009-06-19)
More Articles from Health Business Week
- 3DIcon Corporation
3DIcon Files Provisional Patent Application for High-Resolution “Emissive” Projection Screen - 3M
3M Announces Management Changes - 3M
3M Introduces Wrist Strap and Ground Monitor 773 for Electronics Assembly - 4SC AG
4SC Presents New Pre-clinical Inflammatory Bowel Disease Data on 4SC-101 at Digestive Disease Week - A.P. Pharma, Inc.
A.P. Pharma Announces Additional Restructuring Effort - AAA Michigan
Helmet Law Repeal Will Increase Health Care, Auto Insurance Costs - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
